SCHEMBL9101247

SCHEMBL9101247

N#CC(=CO)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
HIF1A Q16665 1/20 0.49
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
MAPK1 P28482 2/20 0.47
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
MAPT P10636 3/20 0.47
NPC1 O15118 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 1/20 0.45
MMP14 P50281 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9426915 1.00 CES1 (0.50) CES1CYP1A2CYP3A4HIF1ACA1
SCHEMBL14156089 1.00 CES1 (0.50) CES1CYP1A2CYP3A4HIF1ACA1
SCHEMBL15727530 0.86 CYP1A2 (0.52) CES1CYP1A2CYP3A4HIF1ACA1
SCHEMBL29483454 0.84 CES1 (0.48) CES1CYP1A2CYP3A4HIF1ACA1
SCHEMBL10881590 0.83 MAPT (0.62) CES1CYP1A2CYP3A4HIF1ATDP1
SCHEMBL10881599 0.83 MAPT (0.62) CES1CYP1A2CYP3A4HIF1ATDP1
SCHEMBL10881593 0.83 MAPT (0.62) CES1CYP1A2CYP3A4HIF1ATDP1
SCHEMBL11450372 0.83 MAPT (0.62) CES1CYP1A2CYP3A4HIF1ATDP1
SCHEMBL11450371 0.83 MAPT (0.62) CES1CYP1A2CYP3A4HIF1ATDP1
SCHEMBL3589274 0.80 CYP1A2 (0.48) CES1CYP1A2CYP3A4HIF1ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428939-B1 Cumarin derivatives, process for their preparation, their use and thiazolylacetic acid derivatives as intermediate BAYER AG (DE) 1996-01-17 EP disclosed
US-5300656-A Immunoassay BAYER AKTIENGESELLSCHAFT (DE) 1994-04-05 US disclosed
EP-0428939-A2 Cumarin derivatives, process for their preparation, their use and thiazolylacetic acid derivatives as intermediate BAYER AG (DE) 1991-05-29 EP disclosed